Enzo Biochem, Inc.
ENZBOTCHealthcare
$0.70
$-0.00(-0.16%)
Market Cap$36587801
P/E Ratio—
52W High$1.19
52W Low$0.252
Enzo Biochem, Inc. (ENZB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ENZB · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-07 | 2023-07 | 2022-07 | 2021-07 | 2020-07 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $31.91M | $31.06M | $107.07M | $117.73M | $76.02M |
| Cost of Revenue | $17.27M | $19.50M | $65.10M | $64.15M | $52.25M |
| Gross Profit | $14.63M | $11.57M | $41.97M | $53.58M | $23.77M |
| Gross Margin %(computed) | 45.86% | 37.24% | 39.20% | 45.51% | 31.27% |
| Operating Expenses | |||||
| R&D Expenses | $2.64M | $3.90M | $3.77M | $3.25M | $4.45M |
| G&A Expenses | $24.36M | $27.20M | $53.71M | $44.91M | $49.69M |
| Total Operating Expenses | $24.36M | $31.11M | $57.47M | $48.16M | $47.41M |
| Operating Income | ($9.82M) | ($24.74M) | ($15.51M) | $9.88M | ($23.64M) |
| Operating Margin %(computed) | -30.77% | -79.64% | -14.48% | 8.39% | -31.09% |
| Interest Income | $3.54M | $0.28M | $0.18M | $0.01M | $0.45M |
| Interest Expense | $0.20M | $1.40M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($9.82M) | ($25.02M) | ($18.26M) | $7.88M | ($28.52M) |
| Income Tax Expense | $0.00M | $0.00M | $4.32M | $0.00M | $0.00M |
| Net Income | ($26.08M) | $20.29M | ($22.58M) | $3.42M | ($33.89M) |
| Net Margin %(computed) | -81.73% | 65.32% | -21.09% | 2.91% | -44.58% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.51 | $-1.27 | $-0.46 | $0.07 | $-0.71 |
| Wtd Avg Shares | 50.90M | 49.16M | 48.59M | 48.19M | 47.70M |
| EBITDA | ($8.35M) | ($22.34M) | ($15.01M) | $3.35M | ($27.59M) |
| EBITDA Margin %(computed) | -26.16% | -71.92% | -14.02% | 2.84% | -36.29% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Enzo Biochem, Inc. data
About Enzo Biochem, Inc. (ENZB) Income Statement
Enzo Biochem, Inc. (ENZB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, ENZB reported revenue of $0.03B, gross profit of $0.01B (gross margin 45.86%), and net income of ($0.03B) — a net profit margin of -81.73%.
Frequently asked questions
ENZB · 4 questionsEnzo Biochem, Inc. (ENZB) reported revenue of $0.03B for 2024, up 2.7% year-over-year.
ENZB revenueENZB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09